People
Matt Clark
Partner & Managing Director, EMEA Leader, Retail
London
The emergence of GLP-1 agonists in the UK presents significant opportunity – and potential threat – to retail and consumer goods organisations.
Matt Clark, Partner & Managing Director at AlixPartners, and Alex Gourlay, Executive Chair at Holland & Barrett, discuss the potential implications for these sectors, the strategies to consider to harness this disruptive change, and the potential evolution in consumer behaviours as the pace of adoption accelerates.
You can also read our report, detailing the potential implications for Retail below, or download here.